GeoPharma Announces Fiscal Year 2009 Year End Results Release Date and Conference...

GeoPharma Announces Fiscal Year 2009 Year End Results Release Date and
Conference Call

LARGO, Fla., June 29, 2009 (GLOBE NEWSWIRE) -- GeoPharma, Inc. (Nasdaq:GORX)
(the "Company") announced today that it will host a conference call to discuss
the year end results of the fiscal year 2009 and fourth quarter, which ended
March 31, 2009. Financial results will be released before the market opens on
Tuesday, June 30, 2009 with the conference call to follow at 9:00 AM (ET). The
conference call will be hosted by GeoPharma, Inc. CEO, Mihir Taneja and Sr.
VP/CFO, Carol Dore-Falcone. Participants may dial in 15 minutes before the call
is set to begin to register. The dial in number for participants is
1-877-795-3649 and 1-719-325-4764 for international callers. The Conference
Confirmation code is 1378429

Listen via Internet: http://gorx.client.shareholder.com/

Replay of the call will be available from 12 noon ET on June 30th, through
Tuesday, July 14th. The Replay of the call may be heard by dialing
1-888-203-1112 or 1-719-457-0820 for international callers. The Replay Pass Code
is 1378429. Participants may also choose to listen to the call via webcast
through the link in the events and presentations section of the Investor
Relations page of the GeoPharma website located at http://www.geopharmainc.com.

ABOUT GEOPHARMA, INC.: GeoPharma, Inc. is a rapidly growing Bio/Pharma company
with a diversified business model participating in 3 main market segments:
Specialty Pharma, Manufacturing, and Distribution. The Specialty Pharma division
specializes in the formulation of generic drugs for human and veterinary usage
and the development of medical devices used by oncologists and other medical
professionals. The Manufacturing and Distribution divisions, manufacture,
package, and distribute generic drugs, nutraceuticals, cosmetics, and functional
food products for companies worldwide.

The GeoPharma, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=5384

FORWARD LOOKING STATEMENTS

This press release may contain statements, which constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of
1995, including those regarding the company and its subsidiaries' expectations,
intentions, strategies and beliefs pertaining to future performance. All
statements contained herein are based upon information available to the
company's management as of the date hereof, and actual results may vary based
upon future events, both within and without management's control. Important
factors that could cause such differences are described in the company's
periodic filings with the Securities and Exchange Commission.

-0-
CONTACT: GeoPharma, Inc.
Alexander Nachman
727-471-0850 x 243
IR@Geopharmainc.com